{"nctId":"NCT04058158","briefTitle":"A Study to Compare SB12 (Proposed Eculizumab Biosimilar) to Soliris in Subjects With Paroxysmal Nocturnal Haemoglobinuria","startDateStruct":{"date":"2019-08-07","type":"ACTUAL"},"conditions":["Paroxysmal Nocturnal Hemoglobinuria"],"count":50,"armGroups":[{"label":"Treatment Sequence I","type":"EXPERIMENTAL","interventionNames":["Drug: SB12 (proposed eculizumab biosimilar)","Drug: Soliris (eculizumab)"]},{"label":"Treatment Sequence II","type":"EXPERIMENTAL","interventionNames":["Drug: SB12 (proposed eculizumab biosimilar)","Drug: Soliris (eculizumab)"]}],"interventions":[{"name":"SB12 (proposed eculizumab biosimilar)","otherNames":[]},{"name":"Soliris (eculizumab)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female aged 18 or older\n* Eculizumab-naïve patients with PNH\n* Presence of the PNH white blood cell (WBC) clone ≥ 10%\n* Documented LDH level ≥ 1.5 x ULN at Screening\n* History of transfusion for anaemia within 12 months prior to Screening or having PNH-related symptoms at Screening\n* Subjects must be vaccinated against Neisseria meningitides\n\nExclusion Criteria:\n\n* Previous treatment with any complement pathway inhibitors\n* ANC ≤ 500/mm3 or Platelet count \\< 70,000/mm3\n* History of meningococcal disease\n* History of bone marrow transplantation\n* Known or suspected active bacterial/viral/fungal infection within 30 days\n* Stable use of erythropoietic, corticosteroids, heparin, warfarin before randomisation","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Lactate Dehydrogenase (U/L) at Week 26","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"284.20","spread":"456.73"},{"groupId":"OG001","value":"249.72","spread":"103.67"}]}]}]},{"type":"PRIMARY","title":"Time-adjusted AUEC of LDH From Week 14 to Week 26 and From Week 40 to Week 52","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"279.65","spread":"325.37"},{"groupId":"OG001","value":"258.73","spread":"95.09"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":47},"commonTop":["Corona virus infection","Haemoglobinuria","Diarrhoea","Alanine aminotransferase increased","Headache"]}}}